Novo Nordisk stocks soar up on newest weight reduction trial effects Monetary TimesNovo Nordisk inventory pops on Section 1 information for brand new weight reduction drug amycretin Yahoo FinanceNovo Nordisk stocks pop 14% on early-stage weight reduction drug trial effects CNBCOzempic maker’s inventory surges. An ordeal of a brand new Novo Nordisk drug presentations promise. MarketWatch
